Issuance of Stock Acquisition Rights to Directors
First written in FY2017-Q3. 7 of 24 entries say "Restated". Latest entry: FY2026-H1.
- FY2026-H1Exercise of existing stock acquisition rightsAnnual report
「In addition, the company disposed of 26,700 treasury shares through the exercise of stock acquisition rights.」
The company disposed of 26,700 treasury shares through the exercise of existing stock acquisition rights, rather than through the issuance of new stock acquisition rights. - FY2025-H1RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the interim accounting period. - FY2024Continued exercise of existing stock acquisition rightsAnnual report
「Exercised: 3,800 3,400 3,100 / Remaining unexercised: 27,400 26,100 24,000」
A total of 10,300 shares were exercised under existing stock acquisition rights granted to directors, and the remaining unexercised amounts under each plan were disclosed. - FY2024-Q3RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the third quarter accounting period. - FY2024-Q2RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the second quarter accounting period. - FY2024-Q1Exercise of existing stock acquisition rightsAnnual report
「During the first quarter accounting period, the company disposed of 10,300 treasury shares through the exercise of stock options.」
The company disposed of 10,300 treasury shares through the exercise of existing stock options, rather than through the issuance of new stock acquisition rights. - FY2023-Q3RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the third quarter accounting period. - FY2023-Q2RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the second quarter accounting period. - FY2022-Q3RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or other instruments were issued during the third quarter accounting period. - FY2022-Q2No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the second-quarter accounting period. - FY2022-Q1No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the first-quarter accounting period. - FY2021No new issuance; existing stock acquisition rights remain outstandingAnnual report
「Series 1 Stock Acquisition Rights: 312 units; Series 2 Stock Acquisition Rights: 295 units; Series 3 Stock Acquisition Rights: 271 units / Categories and number of grantees: 4 directors, excluding outside directors / Exercise periods: 3 September 2016 to 2 September 2056; 6 June 2017 to 5 June 2057; 6 June 2018 to 5 June 2058」
The disclosure concerns the outstanding status of existing stock acquisition rights granted to directors, rather than the issuance of new rights. - FY2021-Q3No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the third-quarter accounting period. - FY2021-Q2No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the second-quarter accounting period. - FY2021-Q1No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the first-quarter accounting period. - FY2020Exercise of existing stock acquisition rightsAnnual report
「During the consolidated fiscal year, 16,900 shares under the 2016 Series 1 Stock Acquisition Rights, 23,300 shares under the 2017 Series 2 Stock Acquisition Rights, and 21,300 shares under the 2018 Series 3 Stock Acquisition Rights were exercised.」
Rather than a new issuance, a total of 61,500 shares under existing stock acquisition rights granted to directors were exercised. - FY2020-Q3No new issuanceAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the third-quarter accounting period. - FY2020-Q2No new issuanceAnnual report
「① Details of the stock option plan: Not applicable. / ② Status of other stock acquisition rights, etc.: Not applicable.」
It states that there were no new issuances of stock acquisition rights or similar instruments during the second-quarter accounting period. - FY2020-Q1Exercise of existing stock acquisition rightsAnnual report
「Through the exercise of stock options, the company disposed of 61,500 of its common shares during the first-quarter accounting period.」
Although no new stock acquisition rights were issued, the company disposed of 61,500 common shares through the exercise of existing stock options. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second-quarter accounting period were as follows. / Number of stock acquisition rights (units): 484 / Number of shares underlying the stock acquisition rights: 48,400 / Exercise period: 5 June 2018 to 4 June 2058」
During the second-quarter accounting period, the company issued 484 stock acquisition rights covering 48,400 shares and established an exercise period from 5 June 2018 to 4 June 2058. - FY2018AdvancedAnnual report
「2017 Series 2 Stock Acquisition Rights / Categories and number of grantees: 10 company directors, excluding outside directors / Common shares: 52,800 shares / Exercise period: 6 June 2017 to 5 June 2057」
For the 2017 Series 2 Stock Acquisition Rights, the full-year disclosure confirms the grant and vesting of rights covering 52,800 shares to 10 directors, together with the long exercise period. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second-quarter accounting period were as follows. / Number of stock acquisition rights (units): 528 / Number of shares underlying the stock acquisition rights: 52,800 / Exercise period: 6 June 2017 to 5 June 2057」
During the second-quarter accounting period, the company issued 528 stock acquisition rights covering 52,800 shares under the same scheme as that for directors. - FY2017RestatedAnnual report
「2016 Series 1 Stock Acquisition Rights / Categories and number of grantees: 8 company directors, excluding outside directors / Number of shares underlying the stock acquisition rights: 48,100 / Exercise period: 3 September 2016 to 2 September 2056」
The full-year disclosure continues to state the grant of stock acquisition rights covering 48,100 shares to 8 directors and the long exercise period. - FY2017-Q3First statedAnnual report
「The stock acquisition rights issued during the third-quarter accounting period were as follows. / Number of stock acquisition rights (units): 481 / Number of shares underlying the stock acquisition rights: 48,100 / Exercise period: 3 September 2016 to 2 September 2056」
During the third-quarter accounting period, the company issued 481 stock acquisition rights covering 48,100 shares and stated an exercise period from 3 September 2016 to 2 September 2056. Holders of the stock acquisition rights may exercise them from the day after they cease to hold the position of director.